首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷分子呈像/呈影劑

市場調查報告書

商品編碼

1736732

2026 年至 2032 年全球顯影劑注射器市場（按產品類型、應用、最終用戶和地區分類）

Global Contrast Media Injectors Market By Type (Single Head, Dual Head) Product (Consumables, Injector Systems), Application (Radiology, Interventional Radiology), End-User (Hospitals, Diagnostic Imaging Centers), & Region for 2026-2032

出版日期: 2025年05月06日 | 出版商:

Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄

全球顯影劑注射器市場評估 - 2026-2032

顯影劑劑注射器的需求不斷成長，這得益於心臟影像、血管造影術和電腦斷層掃描等微創手術的興起。這些手術中使用顯影劑來提高內部結構和動脈的可見度。隨著這些手術變得越來越頻繁和先進，顯影劑注射技術需要準確和高效。此外，準確的診斷和病人安全至關重要。為了應對這些挑戰，正在開發顯影劑注射器。自動注射通訊協定、即時劑量監測以及與不同配方的顯影劑的兼容性等功能可確保準確的顯影劑注射和降低副作用風險。數據管理功能可以準確記錄注射設置，從而實現更準確的診斷並最大限度地減少再次手術的需要。作為市場擴張的驅動力，市場規模預計將在 2024 年超過 20.7 億美元，到 2032 年將達到 35.1 億美元。

此外，顯影劑注射器市場正經歷兩個關鍵領域的技術進步：效率和安全性。高壓注射器正在開發中，以便更快地輸送造影劑，從而在心臟影像成像等時間敏感的檢查中提供更高品質的影像。對於需要更精細控制的流程，低壓顯影劑可以精確調整流量。除了注射速度和控制之外，自動化方案和即時劑量監測等改進也提高了準確性並減少了錯誤。此外，與各種顯影劑配方的兼容性為有特殊需求的患者提供了更多治療可能性。這些綜合發展使顯影劑劑注射成為醫療保健專業人員更安全、更有效、用途更廣泛的工具。預計2026年至2032年期間，該市場的複合年成長率將達到7.58%左右，並在未來幾年穩步成長。

顯影劑注射器的全球市場定義/概述

顯影劑注射器是醫療設備，用於在X光、電腦斷層掃描和MRI等成像過程中將顯影劑輸送到血液中。這些顯影劑有助於觀察內部結構，並提高這些影像技術的診斷準確性。顯影劑注射器旨在將精確、可控的顯影劑劑量輸送到血液中，以確保最佳影像品質並最大限度地減少患者不適。

顯影劑注射器廣泛應用於各醫學專科領域，包括放射科、循環系統、腫瘤科、神經科和介入放射科。顯影劑注射器用於在診斷影像過程中增強血管、器官和其他結構的可視性，從而有助於診斷和監測病情。顯影劑注射器是精準有效醫療照護的重要工具。

安全性和有效性更高的新型顯影劑的開發將增強這些設備的診斷能力。此外，與其他醫學影像處理技術的整合以及人工智慧的日益普及，將使顯影劑注射器在個人化醫療和精準診斷中發揮更重要的作用。隨著醫療技術的不斷發展，顯影劑注射器仍將是提供精準有效醫療服務的重要工具。

全球慢性疾病患者的增加如何推動顯影劑注射器的全球發展？

全球顯影劑注射器市場正經歷顯著成長，這得益於慢性病患病率的上升以及對診斷影像學程序日益成長的需求。根據世界衛生組織 (WHO) 2022 年的報告，心血管疾病仍然是全球最大的死亡原因，佔全球總死亡人數的 31%。心血管疾病的高發生率導致診斷影像學程序激增，從而刺激了對顯影劑注射器的需求。

顯影劑劑注射器的技術進步也是市場成長的主要驅動力。這些創新不僅提高了診斷成像的效率和準確性，還改善了患者的舒適度和安全性。美國食品藥物管理局)報告稱，2024 年新醫療影像設備的核准與前一年同期比較增加 12%，這表明市場上創新產品線十分豐富。

全球老年人口的成長也大大促進了顯影劑注射器市場的成長。由於與老齡化相關的健康問題，老年人通常需要更頻繁地進行影像檢查。根據聯合國《2022年世界人口展望》報告，預計到2050年，65歲以上人口將從2021年的7.61億加倍，達到16億。

法規遵循和安全問題如何阻礙全球顯影劑注射器市場的成長？

全球顯影劑注射器市場在法規遵循和安全方面面臨重大挑戰。世界各地衛生部門實施的嚴格法規要求製造商不斷更新和改進其產品，以滿足不斷發展的安全標準。根據美國食品藥物管理局(FDA) 2024 年醫療設備不利事件報告，2022 年共報告了 1,235 起與造影劑注射器相關的事件，凸顯了持續加強安全措施的必要性。

另一個挑戰是先進顯影劑注射器的高成本，這可能會限制其在開發中國家和小型醫療機構的普及。這一成本障礙加劇了醫療品質和診斷能力的地區差異。根據世界衛生組織 (WHO) 2024 年全球衛生支出資料庫，低收入國家的人均醫療設備設備支出僅 40 美元，而高所得國家的人均醫療設備支出則為 340 美元。

全球持續的碘顯影劑短缺為顯影劑注射器市場帶來了重大挑戰。這種短缺影響了注射器的使用率，並影響了全球的診斷成像程序。美國醫院協會於2024年5月報告稱，78%的受訪醫院正面臨中度至重度碘顯影劑短缺，導致重要的診斷程序延誤。

The increasing demand for these injectors is being driven by the increase in minimally invasive treatments such as heart imaging, angiography, and CT scans. Contrast chemicals are used in these procedures to improve the imaging's visibility of interior structures and blood arteries. Contrast media injection technology needs to be accurate and efficient as these procedures become more frequent and sophisticated. Furthermore, Accurate diagnosis and patient safety are of utmost importance. To solve these issues, contrast media injectors are being developed. Accurate contrast delivery and reduced risk of adverse responses are ensured by features including automated injection protocols, real-time dose monitoring, and compatibility with different formulations of contrast media. The ability to precisely record injection settings through data management capabilities makes it possible to make more accurate diagnoses and maybe minimize the need for repeat surgeries, driving market expansion is predicted to push market sales above USD 2.07 Billion in 2024 and reach USD 3.51 Billion by 2032.

Furthermore, The Contrast Media Injectors Market is experiencing a boom in technological improvements on two critical fronts: efficiency and safety. High-pressure injectors are being developed to provide contrast media faster, resulting in better image quality for time-sensitive operations such as cardiac imaging. For processes that require more careful control, low-pressure injectors provide exact flow regulation. Aside from injection speed and control, improvements such as automated protocols and real-time dose monitoring enhance precision and reduce errors. Furthermore, compatibility with different contrast media formulations broadens therapeutic possibilities for individuals with special requirements. These combined developments are making contrast media injection a safer, more effective, and versatile tool for medical professionals. The market is expected to rise steadily in the coming years to grow at a CAGR of about 7.58% from 2026 to 2032.

Global Contrast Media Injectors Market: Definition/ Overview

Contrast media injectors are medical devices used to deliver contrast agents into the bloodstream during imaging procedures such as X-rays, CT scans, and MRIs. These contrast agents help to visualize internal structures and improve the diagnostic accuracy of these imaging techniques. Contrast media injectors are designed to deliver a precise and controlled amount of contrast agent into the bloodstream, ensuring optimal image quality and minimizing patient discomfort.

Contrast media injectors have a wide range of applications in various medical specialties, including radiology, cardiology, oncology, neurology, and interventional radiology. They are used to enhance the visibility of blood vessels, organs, and other structures during imaging procedures, helping to diagnose and monitor medical conditions. Contrast media injectors are essential tools for accurate and effective medical care.

The development of new contrast agents with improved safety and efficacy profiles will enhance the diagnostic capabilities of these devices. Furthermore, integration with other medical imaging technologies and the increasing use of artificial intelligence will enable contrast media injectors to play a more significant role in personalized medicine and precision diagnostics. As healthcare technology continues to evolve, contrast media injectors will remain an essential tool for providing accurate and effective medical care.

How are the Rising Cases of Chronic Diseases Worldwide Fueling the Development of Global Contrast Media Injectors Market?

The global contrast media injectors market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and the rising demand for diagnostic imaging procedures. According to the World Health Organization's 2022 report, cardiovascular diseases remain the leading cause of death globally, accounting for 31% of all deaths worldwide. This high incidence of cardiovascular diseases has led to a surge in diagnostic imaging procedures, consequently boosting the demand for contrast media injectors.

Technological advancements in contrast media injectors are another key driver of market growth. These innovations are enhancing the efficiency and accuracy of diagnostic imaging procedures while improving patient comfort and safety. The U.S. Food and Drug Administration reported a 12% increase in the approval of new medical imaging devices in 2024 compared to the previous year, indicating a robust pipeline of innovative products in the market.

The expanding geriatric population worldwide is also contributing significantly to the growth of the contrast media injectors market. Elderly individuals often require more frequent diagnostic imaging procedures due to age-related health issues. According to the United Nations' World Population Prospects 2022 report, the number of persons aged 65 years or over is projected to double from 761 million in 2021 to 1.6 billion in 2050.

How are the Regulatory Compliance and Safety Concerns Hindering the Global Contrast Media Injectors Market Growth?

The global contrast media injectors market faces significant challenges related to regulatory compliance and safety concerns. Stringent regulations imposed by health authorities worldwide require manufacturers to continually update and improve their products to meet evolving safety standards. According to the U.S. Food and Drug Administration's 2024 report on medical device adverse events, there were 1,235 incidents related to contrast media injectors reported in 2022, highlighting the ongoing need for enhanced safety measures.

Another challenge is the high cost associated with advanced contrast media injectors, which can limit their adoption in developing countries and smaller healthcare facilities. This cost barrier contributes to disparities in healthcare quality and diagnostic capabilities across different regions. The World Health Organization's 2024 Global Health Expenditure Database revealed that low-income countries spent an average of just $40 per capita on medical devices and equipment, compared to $340 in high-income countries.

The ongoing global shortage of iodinated contrast media poses a significant challenge to the contrast media injectors market. This shortage affects the utilization of injectors and impacts diagnostic imaging procedures worldwide. The American Hospital Association reported in May 2024 that 78% of hospitals surveyed were experiencing moderate to severe shortages of iodinated contrast media, leading to delays in critical diagnostic procedures.

Category-Wise Acumens

What are the Features Bolstering the Demand of Injector Systems Segment?

The injector systems segment is currently dominating the global contrast media injectors market, driven by their efficiency, precision, and compatibility with various imaging modalities. According to the U.S. Centers for Medicare & Medicaid Services (CMS), in 2024, there was a 12% increase in reimbursement rates for contrast-enhanced imaging procedures using advanced injector systems, reflecting their growing importance in diagnostic imaging.

The market's growth is further propelled by technological advancements and product innovations. For instance, on February 18, 2024, Medrad, Inc., a subsidiary of Bayer, launched a new AI-powered contrast media injector system that optimizes contrast dosage based on patient-specific parameters, potentially reducing contrast-related adverse events by up to 30% in clinical trials.

What Factors are Responsible to Project the Market Growth of Hospitals Segment?

The hospitals segment currently holds a dominant position in the global contrast media injectors market, driven by their high patient volumes and advanced diagnostic imaging capabilities. According to the American Hospital Association's 2024 Annual Survey, U.S. hospitals performed over 150 million diagnostic imaging procedures in 2022, with a significant portion requiring contrast media injectors. This dominance is further reinforced by hospitals' ability to invest in cutting-edge medical technologies.

The hospital segment's prominence in the contrast media injectors market is also attributed to the increasing prevalence of chronic diseases requiring advanced diagnostic imaging. The Centers for Disease Control and Prevention (CDC) reported in its 2024 National Health Interview Survey that 51.8% of U.S. adults had at least one chronic condition, necessitating regular diagnostic procedures. Hospitals are well-equipped to handle complex cases and emergency situations where rapid, high-quality imaging is crucial.

How are the Rising Cases of Chronic Diseases Worldwide Fueling the Development of Global Contrast Media Injectors Market?

How are the Regulatory Compliance and Safety Concerns Hindering the Global Contrast Media Injectors Market Growth?

Category-Wise Acumens

What are the Features Bolstering the Demand of Injector Systems Segment?

What Factors are Responsible to Project the Market Growth of Hospitals Segment?

Country/Region-wise

How will the Advanced Healthcare Infrastructure North America Propels the Contrast Media Injectors Market Growth?

North America has maintained its dominance in the global contrast media injectors market, driven by advanced healthcare infrastructure and high adoption rates of medical imaging technologies. According to the U.S. Centers for Medicare & Medicaid Services (CMS), healthcare spending in the United States reached $4.3 trillion in 2022, with a significant portion allocated to diagnostic imaging services. This substantial investment has enabled healthcare facilities to acquire state-of-the-art contrast media injectors and related technologies.

The region's market dominance is further reinforced by the high prevalence of chronic diseases and an aging population, both of which contribute to increased demand for diagnostic imaging procedures. The U.S. Census Bureau projected in its 2024 report that by 2032, all baby boomers will be older than 65, expanding the pool of patients requiring regular medical imaging. For instance, on March 3, 2024, Bracco Diagnostics Inc. launched a new contrast media injector specifically designed for geriatric patients, featuring enhanced safety protocols and ease of use for elderly individuals undergoing diagnostic procedures, further solidifying North America's position at the forefront of the contrast media injectors market.

How the Increasing Healthcare Investments Supports the Market Growth in the Asia-Pacific?

The Asia-Pacific contrast media injectors market is anticipated to grow at a rapid CAGR during the forecast period, driven by increasing healthcare investments and a rising prevalence of chronic diseases. According to the Indian Ministry of Health and Family Welfare, the country's healthcare sector is expected to reach $372 billion by 2025, indicating a surge in medical infrastructure and advanced diagnostic equipment adoption. This growth is further bolstered by the expanding geriatric population and the growing demand for minimally invasive procedures across the region.

Key market players are actively contributing to this growth through strategic initiatives and product innovations. For instance, on March 15, 2024, Bracco Imaging announced the launch of its new EmpowerCTA(R)+ Injector System in Japan, featuring advanced safety protocols and improved workflow efficiency. This move highlights the industry's focus on enhancing patient care and operational effectiveness in the APAC region. The combination of government support, increasing healthcare expenditure, and ongoing technological advancements positions APAC as a prime market for contrast media injectors in the coming years.

Competitive Landscape

The global contrast media injectors market is a dynamic and competitive landscape, with a mix of established players and emerging challengers vying for market share. These players are actively working to strengthen their presence by implementing strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are dedicated to continuously improving their product line to meet the needs of a wide range of customers in different regions.

Some of the key players operating in the global contrast media injectors market include:

Bayer HealthCare LLC, Bracco Group, Ulrich Medical, Guerbet Group, Medtron AG, Nemoto Kyorindo Co., Ltd., Hong Kong Medi Co Limited, GE Healthcare (GE Company).

Latest Developments

In December 2021, Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent, will be the subject of a global partnership between Guerbet and Bracco Imaging.

In December 2021, to address the demands of hospitals and imaging networks, Qaelum NV established a strategic agreement with Ulrich GmbH & Co. KG in Ulm. This partnership will allow Qaelum to integrate their cutting-edge Contrast Management technology with Ulrich Medical's contrast media injectors.

1 INTRODUCTION OF GLOBAL CONTRAST MEDIA INJECTORS MARKET

1.1 Introduction of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CONTRAST MEDIA INJECTORS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT

5.1 Overview
5.2 Injector Systems
- 5.2.1 CT injector systems
- 5.2.2 MRI injector systems
- 5.2.3 Cardiovascular/angiography injector systems
5.3 Consumables
- 5.3.1 Tubing
- 5.3.2 Syringe
- 5.3.3 Interventional Radiology

6 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION

6.1 Overview
6.2 Radiology
6.3 Interventional Cardiology
6.4 Interventional Radiology

7 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY END-USER

7.1 Overview
7.2 Hospitals
7.3 Diagnostic Imaging Centers

8 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL CONTRAST MEDIA INJECTORS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Bayer HealthCare LLC
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Bracco Group
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Ulrich Medical
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Guerbet Group
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Medtron AG
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Nemoto Kyorindo Co., Ltd.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Hong Kong Medi Co Limited
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 GE Healthcare (GE Company)
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments